Petersen Floyd F.'s Form 4 filing
Amphastar Pharmaceuticals, Inc. (AMPH) · filed Mar 4, 2024
- Accession no.
- 0001415889-24-006440
- Filed
- Mar 4, 2024
- Trade date
- Mar 1, 2024
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $22.8K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Petersen Floyd F.CIK 0001611286 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2024 | Common Stock | SSaleDisposed | −451 | $45.60 | −$20,565.6 | 79,882 | Direct | |
| Mar 1, 2024 | Common Stock | SSaleDisposed | −49 | $46.53 | −$2,279.97 | 79,833 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.